Company / Assets per Share
Sunshine Biopharma Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$11.66
FY2025
5-year range
$1.21 / $2181.02
FY2021-FY2025
Trend
-99.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2016 to $2181.02 in FY2024.
Based on SEC 10-K filings.
11.66 in FY2025 with a 5-year CAGR of +230.4%.
Improved from $1.21 to $11.66 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +230.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 99.5% year-over-year.
- Peak assets per share was recorded in FY2024.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.66 | -99.5% |
| FY2024 | $2181.02 | +180028.3% |
| FY2023 | $1.21 | -89.3% |
| FY2022 | $11.29 | +787.4% |
| FY2021 | $1.27 | +4196.6% |
| FY2020 | $0.03 | +29.2% |
| FY2019 | $0.02 | -8.2% |
| FY2018 | $0.02 | +7358.3% |
| FY2017 | $0.00 | +3.0% |
| FY2016 | $0.00 | -96.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026